GeneMatrix Inc. (KOSDAQ: 109820)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,750.00
-45.00 (-1.61%)
Dec 17, 2024, 12:32 PM KST
-9.09%
Market Cap 55.88B
Revenue (ttm) 4.72B
Net Income (ttm) -2.09B
Shares Out 20.39M
EPS (ttm) -123.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 66,383
Open 2,815.00
Previous Close 2,795.00
Day's Range 2,730.00 - 2,815.00
52-Week Range 2,270.00 - 7,180.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About GeneMatrix

GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and contro... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2000
Employees 31
Stock Exchange KOSDAQ
Ticker Symbol 109820
Full Company Profile

Financial Performance

In 2018, GeneMatrix's revenue was 4.73 billion, a decrease of -8.75% compared to the previous year's 5.19 billion. Losses were -3.11 billion, 111.4% more than in 2017.

Financial Statements

News

There is no news available yet.